OPTIMIZATION AND CHARACTERIZATION OF CONTROLLED-RELEASE PELLETS COATED WITH AN EXPERIMENTAL LATEX .1. ANIONIC DRUG

被引:66
作者
SINGH, SK
DODGE, J
DURRANI, MJ
KHAN, MA
机构
[1] NE LOUISIANA UNIV,SCH PHARM,DIV MED CHEM & PHARMACEUT,MONROE,LA 71209
[2] BF GOODRICH CO,DIV SPECIALTY POLYMERS & CHEM,BRECKSVILLE RES CTR,CLEVELAND,OH 44141
关键词
CONTROLLED RELEASE; PELLET; COATING; LATEX; OPTIMIZATION; IBUPROFEN; BOX-BEHNKEN DESIGN; DISSOLUTION; X-RAY DIFFRACTION;
D O I
10.1016/0378-5173(95)00135-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of the present study was to evaluate the suitability of an experimental latex as a controlled release coating dispersion by preparing, optimizing and characterizing pellets of ibuprofen. A laboratory size fluidized bed coating machine (Uniglatt M-2817) was used to coat ibuprofen loaded beads with the experimental latex to release 400 mg of ibuprofen in a 12 h period in pH 7.2 phosphate buffer. Independent variables such as solids content, volume of coating dispersion, and plasticizer concentration were optimized using a three-factor, three-level Box-Behnken design. The response studied was cumulative percentage dissolved in 12 h with constraints on 1, 6 and 12 h. Surface response plots were utilized to relate the dependent and the independent variables. The optimization procedure generated a maximum of 86% release in 12 h when the levels of solids content, volume of coating dispersion and plasticizer concentration were 11.06% w/w, 113.7 mi, and 26.59% w/w respectively. The optimized pellets prepared based on the predicted levels yielded response values which were close to the predicted values. The kinetics of release was shown to follow Baker-Lonsdale model. The formulations were characterized using DSC, SEM and X-ray diffraction studies. Comparative evaluation with other commercial preparations indicated that the experimental latex provides a more efficient release of the anionic drug, ibuprofen.
引用
收藏
页码:243 / 255
页数:13
相关论文
共 13 条
[1]  
BAKER RW, 1987, CONTROLLED RELEASE B, P15
[2]   RELEASE MECHANISMS IN GELFORMING SUSTAINED-RELEASE PREPARATIONS [J].
BAMBA, M ;
PUISIEUX, F ;
MARTY, JP ;
CARSTENSEN, JT .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1979, 2 (5-6) :307-315
[3]  
Banker GS, 1981, PHARM TECHNOL, V5, P55
[4]  
Box G.E.P., 1960, TECHNOMETRICS, V2, P455, DOI [DOI 10.2307/1266454, DOI 10.1080/00401706.1960.10489912]
[5]  
Follonier N., 1992, STP PHARMA SCI, V2, P141
[6]  
HERTZFELDT CD, 1983, DRUG DEV IND PHARM, V9, P767
[8]  
HIXON AW, 1931, IND ENG CHEM, V23, P923
[9]   PHYSICAL CHARACTERIZATION AND DISSOLUTION PROPERTIES OF IBUPROFEN - EUDRAGIT COPRECIPITATES [J].
KISLALIOGLU, MS ;
KHAN, MA ;
BLOUNT, C ;
GOETTSCH, RW ;
BOLTON, S .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1991, 80 (08) :799-804
[10]   DISSOLUTION RATE STUDIES .1. CONTINOUS RECORDING TECHNIQUE FOR FOLLOWING RAPID REACTIONS IN SOLUTION [J].
NIEBERGALL, PJ ;
GOYAN, JE .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1963, 52 (01) :29-&